Literature DB >> 11464577

Alternative embryo transfer on day 3 or day 5 for reducing the risk of multiple gestations.

H G Yoon1, S H Yoon, W Y Son, J G Kim, K S Im, J H Lim.   

Abstract

PURPOSE: This study was carried out to reduce the possibility of high-order multiple gestations and the failure of embryo transfer by determining their replacement date based on the number and quality of 2-day embryos.
METHODS: All zygotes were cocultured with cumulus cells in 10 microliters of YS medium containing 10% human follicular fluid (hFF) for 48 or 96 hr. In period I, all embryos were transferred on day 3 (1032 cycles). In period II, the embryos were transferred on either day 3 or day 5 by determining their replacement date based on the number and quality of 2-day embryos: there were 2701 patients in whom embryos were replaced on day 3 (in the case that the number of zygotes was less than eight and the number of good-quality embryos was less than three) and 1952 patients less than 40 years old in whom embryos were replaced on day 5 (in the case that the number of zygotes was eight or more and/or the number of good-quality embryos was three or more). On the other hand, patients who were 40 years old or more were alloted to day 3 transfer cycles, regardless of the number and quality of the 2-day embryos, due to the possibility of their not producing blastocyst-stage embryos in vitro.
RESULTS: The number of embryos transferred in period II was 2.9 +/- 0.6, while that in period I was 3.7 +/- 0.5. The multiple pregnancy rate was significantly decreased in period II (30.7%) compared to that (49.6%) in period I, while the pregnancy and implantation rates in period II (36.1 and 16.4%, respectively) were not lower than those (34.9 and 16.1%, respectively) in period I. The rate of triplet or more gestations was significantly minimized in period II (2.3%) compared to that in period I (26.5%).
CONCLUSIONS: We propose that determination of the date on which embryos should be transferred based on the number and quality of embryos on day 2 may help to maintain an acceptable pregnancy rate, while minimizing embryo transfer failure and high-order multiple gestations.

Entities:  

Mesh:

Year:  2001        PMID: 11464577      PMCID: PMC3455334          DOI: 10.1023/a:1016651016502

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  18 in total

Review 1.  Is the success of human IVF more a matter of genetics and evolution than growing blastocysts?

Authors:  R G Edwards; H K Beard
Journal:  Hum Reprod       Date:  1999-01       Impact factor: 6.918

2.  Two-blastocyst transfer has similar pregnancy rates and a decreased multiple gestation rate compared with three-blastocyst transfer.

Authors:  A A Milki; J D Fisch; B Behr
Journal:  Fertil Steril       Date:  1999-08       Impact factor: 7.329

3.  Glucose-free medium in human in vitro fertilization and embryo transfer: a large-scale, prospective, randomized clinical trial.

Authors:  A Coates; A J Rutherford; H Hunter; H J Leese
Journal:  Fertil Steril       Date:  1999-08       Impact factor: 7.329

4.  Blastocyst transfer in day-5 embryo transfer depends primarily on the number of oocytes retrieved and not on age.

Authors:  M C Scholtes; G H Zeilmaker
Journal:  Fertil Steril       Date:  1998-01       Impact factor: 7.329

5.  Assisted reproductive technology in the United States and Canada: 1995 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

Authors: 
Journal:  Fertil Steril       Date:  1998-03       Impact factor: 7.329

6.  High implantation and pregnancy rates with transfer of human blastocysts developed in preimplantation stage one and blastocyst media.

Authors:  E L Alves da Motta; J R Alegretti; E C Baracat; D Olive; P C Serafini
Journal:  Fertil Steril       Date:  1998-10       Impact factor: 7.329

7.  A prospective, randomized study of embryo transfer results after 3 or 5 days of embryo culture in in vitro fertilization.

Authors:  M C Scholtes; G H Zeilmaker
Journal:  Fertil Steril       Date:  1996-06       Impact factor: 7.329

8.  A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization.

Authors:  D K Gardner; W B Schoolcraft; L Wagley; T Schlenker; J Stevens; J Hesla
Journal:  Hum Reprod       Date:  1998-12       Impact factor: 6.918

9.  Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer.

Authors:  G M Jones; A O Trounson; N Lolatgis; C Wood
Journal:  Fertil Steril       Date:  1998-12       Impact factor: 7.329

10.  The suitability and efficiency of human follicular fluid as a protein supplement in human in vitro fertilization programs.

Authors:  H J Chi; D H Kim; J J Koo; S S Chang
Journal:  Fertil Steril       Date:  1998-11       Impact factor: 7.329

View more
  9 in total

1.  Analysis of clinical outcomes with respect to spermatozoan origin after artificial oocyte activation with a calcium ionophore.

Authors:  Hye Jin Yoon; In Hee Bae; Hyoung Jun Kim; Jung Mi Jang; Yong Su Hur; Hae Kwon Kim; San Hyun Yoon; Won Don Lee; Jin Ho Lim
Journal:  J Assist Reprod Genet       Date:  2013-10-10       Impact factor: 3.412

2.  Clinical outcomes of elective single morula embryo transfer versus elective single blastocyst embryo transfer in IVF-ET.

Authors:  Sang Min Kang; Sang Won Lee; Hak Jun Jeong; San Hyun Yoon; Min Whan Koh; Jin Ho Lim; Seong Goo Lee
Journal:  J Assist Reprod Genet       Date:  2012-03-01       Impact factor: 3.412

3.  Comparison of clinical outcomes between single and double vitrified-warmed blastocyst embryo transfer according to the day of vitrification.

Authors:  Sang Min Kang; Sang Won Lee; San Hyun Yoon; Joo Cheol Kim; Jin Ho Lim; Seong Goo Lee
Journal:  J Assist Reprod Genet       Date:  2013-05-30       Impact factor: 3.412

4.  Vitrification of human early cavitating and deflated expanded blastocysts: clinical outcome of 474 cycles.

Authors:  G A Rama Raju; G Jaya Prakash; K Murali Krishna; K Madan
Journal:  J Assist Reprod Genet       Date:  2009-10-30       Impact factor: 3.412

5.  Optimization of a dilution method for human expanded blastocysts vitrified using EM grids after artificial shrinkage.

Authors:  So-Young Lee; Hyung-Jun Kim; Sung-Jin Park; Hye-Jin Yoon; San-Hyun Yoon; Kyung-Hoon Lee; Won-Don Lee; Jin-Ho Lim
Journal:  J Assist Reprod Genet       Date:  2006-02-09       Impact factor: 3.412

6.  Randomized study comparing day 2 versus day 3 elective transfer of two good-quality embryos.

Authors:  Tatsuya Suzuki; Hiroaki Shibahara; Yuki Hirano; Akiko Ohno; Satoru Takamizawa; Mitsuaki Suzuki
Journal:  Reprod Med Biol       Date:  2004-05-20

7.  Comparison of elective single cleavage-embryo transfer to elective single blastocyst-embryo transfer in human IVF-ET.

Authors:  Sang Min Kang; Sang Won Lee; Hak Jun Jeong; San Hyun Yoon; Jin Ho Lim; Seong Goo Lee
Journal:  Clin Exp Reprod Med       Date:  2011-03-31

8.  Application of two different synthetic sequential media for the human IVF-ET program: a prospective, randomized, and comparative study.

Authors:  Jeong Yoon; Hye-Jin Yoon; Kyoung-Mi Juhn; Jin-Kyung Ko; San-Hyun Yoon; Yong Ko; Jin-Ho Lim
Journal:  Clin Exp Reprod Med       Date:  2011-12-31

9.  Creation, effects on embryo quality, and clinical outcomes of a new embryo culture medium with 31 optimized components derived from human oviduct fluid: A prospective multicenter randomized trial.

Authors:  Takafumi Utsunomiya; Tatsuma Yao; Hiroko Itoh; Yufuko Kai; Yoko Kumasako; Miwa Setoguchi; Naomi Nakagata; Hiroyuki Abe; Motoharu Ishikawa; Koichi Kyono; Hiroaki Shibahara; Osamu Tsutsumi; Yukihiro Terada; Shunsaku Fujii; Kaoru Yanagida; Minesuke Yokoyama; Sueo Niimura; Tsuyoshi Endo; Yoshinori Fukuda; Masato Inoue; Tomohiro Kono; Naoaki Kuji; Fumiko Tawara; Hiroaki Yoshida; Yoshimasa Yokota; Yoshihiro Tada
Journal:  Reprod Med Biol       Date:  2022-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.